Regulation of purine de novo synthesis is governed by feedback inhibition, in which downstream nucleotide products (AMP, GMP) inhibit the enzymes catalyzing earlier and branch-point reactions to maintain balanced production of adenine and guanine nucleotides. This concept belongs to biochemistry/metabolic regulation, specifically nucleotide metabolism, and illustrates the general principle that a pathway's committed and branch-point enzymes serve as control points sensitive to end-product concentrations and cellular energy status. Improper balance between the two nucleotide pools is linked to mutation, underscoring the regulation's role in maintaining genomic fidelity during nucleic acid synthesis.
Regulation of purine de novo synthesis is governed by feedback inhibition, in which downstream nucleotide products (AMP, GMP) inhibit the enzymes catalyzing earlier and branch-point reactions to main…